标题 |
Pathologic complete response (pCR) rates for patients with HR+/HER2- high-risk, early-stage breast cancer (EBC) by clinical and molecular features in the phase II I-SPY2 clinical trial
II期I-SPY2临床试验中HR+/HER2-高危早期乳腺癌(EBC)患者的病理完全缓解(pCR)率(根据临床和分子特征)
|
网址 | |
DOI |
10.1016/j.annonc.2024.10.018
doi
|
求助人 | |
下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |